Orbimed Advisors - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 54 filers reported holding CTI BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2021$22,186,000
+18.0%
7,520,6000.0%0.24%
+28.4%
Q2 2021$18,802,000
-14.1%
7,520,6000.0%0.19%
-7.3%
Q1 2021$21,885,000
-28.6%
7,520,600
-21.0%
0.20%
-23.5%
Q4 2020$30,656,000
+49.8%
9,520,6000.0%0.27%
+4.3%
Q3 2020$20,469,000
+85.3%
9,520,6000.0%0.26%
+65.8%
Q2 2020$11,044,000
+26.1%
9,520,6000.0%0.16%
+5.4%
Q1 2020$8,759,000
+10.9%
9,520,600
+90.4%
0.15%
+30.1%
Q4 2019$7,900,000
+88.8%
5,000,0000.0%0.11%
+43.0%
Q3 2019$4,185,000
-2.6%
5,000,0000.0%0.08%
+17.9%
Q2 2019$4,297,000
-11.4%
5,000,0000.0%0.07%
-10.7%
Q1 2019$4,851,000
+32.3%
5,000,0000.0%0.08%
+10.3%
Q4 2018$3,668,000
-66.0%
5,000,0000.0%0.07%
-47.7%
Q3 2018$10,800,000
-56.6%
5,000,0000.0%0.13%
-56.2%
Q2 2018$24,900,000
+27.7%
5,000,0000.0%0.30%
+22.7%
Q1 2018$19,500,000
+45.5%
5,000,0000.0%0.24%
+43.2%
Q4 2017$13,400,000
-16.0%
5,000,0000.0%0.17%
+11.2%
Q3 2017$15,950,000
-3.6%
5,000,0000.0%0.15%
-12.1%
Q2 2017$16,550,0005,000,0000.17%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q2 2021.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders